LOVETTE ALEGADO: Open Payments
NPI 1043817026 · GALVESTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$196 in 7 payments from 6 companies in 2025. Trend: 2023 $375 · 2024 $461 · 2025 $196
Food & beverage: $196
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| SCPHARMACEUTICALS INC. | 1 | $51 |
| SOBI, INC | 1 | $33 |
| Amgen Inc. | 1 | $22 |
| Aurinia Pharma U.S., Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: FUROSCIX, Gamifant, Fabhalta, Vanrafia, TAVNEOS, LUPKYNIS, JARDIANCE.
Industry payments across TX — which companies pay providers there.
